Towa Pharmaceutical Co., Ltd. (TYO:4553)
Japan
· Delayed Price · Currency is JPY 4,120.00
-80.00 (-1.90%)
Mar 9, 2026, 3:30 PM JST
Towa Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 202,819 | 131,879 | 142,933 | 93,275 | 135,736 | 120,231 | Upgrade
|
| Market Cap Growth | 41.15% | -7.73% | 53.24% | -31.28% | 12.90% | 7.78% | Upgrade
|
| Enterprise Value | 396,658 | 326,106 | 308,406 | 222,967 | 195,152 | 187,298 | Upgrade
|
| Last Close Price | 4120.00 | 2643.28 | 2797.20 | 1788.33 | 2516.48 | 2193.27 | Upgrade
|
| PE Ratio | 9.46 | 6.95 | 8.84 | 42.38 | 8.53 | 8.61 | Upgrade
|
| Forward PE | 10.06 | 8.37 | 11.99 | 11.96 | 8.06 | 10.11 | Upgrade
|
| PS Ratio | 0.75 | 0.51 | 0.63 | 0.45 | 0.82 | 0.78 | Upgrade
|
| PB Ratio | 1.07 | 0.77 | 0.92 | 0.68 | 1.03 | 1.03 | Upgrade
|
| P/TBV Ratio | 1.38 | 1.05 | 1.36 | 1.11 | 1.74 | 1.18 | Upgrade
|
| P/FCF Ratio | 32.00 | - | - | - | 12.35 | 41.88 | Upgrade
|
| P/OCF Ratio | 6.58 | 5.64 | 17.41 | 36.67 | 6.13 | 10.01 | Upgrade
|
| EV/Sales Ratio | 1.47 | 1.26 | 1.35 | 1.07 | 1.18 | 1.21 | Upgrade
|
| EV/EBITDA Ratio | 8.58 | 7.52 | 8.68 | 8.95 | 6.62 | 6.17 | Upgrade
|
| EV/EBIT Ratio | 16.44 | 14.03 | 17.48 | 40.43 | 10.53 | 9.40 | Upgrade
|
| EV/FCF Ratio | 62.58 | - | - | - | 17.76 | 65.24 | Upgrade
|
| Debt / Equity Ratio | 1.23 | 1.38 | 1.32 | 1.26 | 1.09 | 0.73 | Upgrade
|
| Debt / EBITDA Ratio | - | 5.45 | 5.80 | 6.94 | 4.89 | 2.79 | Upgrade
|
| Debt / FCF Ratio | 36.87 | - | - | - | 13.12 | 29.53 | Upgrade
|
| Net Debt / Equity Ratio | 1.02 | 1.11 | 1.13 | 1.09 | 0.84 | 0.53 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.19 | 4.40 | 4.97 | 5.97 | 3.77 | 2.04 | Upgrade
|
| Net Debt / FCF Ratio | 30.58 | -35.78 | -5.96 | -5.68 | 10.13 | 21.54 | Upgrade
|
| Asset Turnover | - | 0.58 | 0.57 | 0.60 | 0.57 | 0.65 | Upgrade
|
| Inventory Turnover | - | 1.58 | 1.51 | 1.64 | 1.43 | 1.61 | Upgrade
|
| Quick Ratio | 1.30 | 1.33 | 1.26 | 1.00 | 0.73 | 1.33 | Upgrade
|
| Current Ratio | 2.84 | 2.81 | 2.72 | 2.33 | 1.45 | 2.67 | Upgrade
|
| Return on Equity (ROE) | - | 11.59% | 11.05% | 1.64% | 12.79% | 12.62% | Upgrade
|
| Return on Assets (ROA) | - | 3.22% | 2.75% | 0.98% | 4.03% | 5.26% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.43% | 4.82% | 3.78% | 1.00% | 6.29% | 8.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 6.10% | 5.00% | 1.90% | 8.60% | 10.30% | Upgrade
|
| Earnings Yield | 10.57% | 14.40% | 11.31% | 2.36% | 11.72% | 11.61% | Upgrade
|
| FCF Yield | 3.12% | -4.04% | -20.74% | -28.07% | 8.10% | 2.39% | Upgrade
|
| Dividend Yield | 1.90% | 2.65% | 2.15% | 3.36% | 2.27% | 2.01% | Upgrade
|
| Payout Ratio | - | 15.55% | 18.25% | 140.84% | 15.15% | 15.52% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | 0.00% | 2.19% | 1.86% | 3.57% | Upgrade
|
| Total Shareholder Return | 1.89% | 2.64% | 2.15% | 5.55% | 4.12% | 5.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.